By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Corporate Headquarters
One Amgen Center Drive
Thousand Oaks  California  91320-1789  U.S.A.
Phone: 805-447-1000 Fax: 805-447-1010



Genesis Research and Development Corporation 

Phylos, Inc.  In 2000, Phylos entered into collaboration with Amgen to apply Phylos' PROfusion™ technology to rapidly identify high-affinity binding agents to potential therapeutic targets supplied by Amgen. Amgen will use the sequences and structural information gained through this collaboration for its internal drug discovery programs.

UCB, Inc.  Contract manufacturing of Abarelix peptide active ingredient

EPIX Pharmaceuticals, Inc. 

Dyax Corp.  Antibody phage display

Company News
Amgen (AMGN) Announces 2014 Third Quarter Dividend 7/28/2014 6:16:44 AM
Amgen (AMGN) Announces Webcast Of 2014 Second Quarter Financial Results 7/25/2014 8:09:24 AM
Amgen (AMGN), Bayer HealthCare (BAY)'s Nexavar Fails Late-Stage Breast Cancer Study 7/25/2014 5:45:10 AM
Amgen (AMGN) Nervous As FDA Paves Way For Novartis AG (NVS) To Copy Drug Neupogen 7/24/2014 7:09:02 AM
Amgen (AMGN) Growth In Brazil Picks Up, Eyes Doubling Portfolio By 2020 7/24/2014 6:02:42 AM
Amgen (AMGN) Thyroid Drug AMG 416 Succeeds In Late Stage Kidney Patient Trial 7/17/2014 3:58:30 PM
That Model Genentech (RHHBY), Gilead Sciences, Inc. (GILD), And Amgen (AMGN) Were Built On—Does It Work Anymore? 7/16/2014 6:15:13 AM
Amgen (AMGN) Spinoff Atara Biotherapeutics Hikes IPO Target From $50 Million To $92 Million 7/11/2014 8:16:49 AM
BIND Therapeutics (BIND) Ends Cancer Drug Pact With Amgen (AMGN); BIND Stock Down -10.02% At Market Close (July 3, 2014) 7/3/2014 7:57:44 AM
Bellerophon Therapeutics Brings In Ex-Amgen (AMGN) Exec For CEO Post 7/2/2014 7:52:47 AM